|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 10-27 | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 10-27 | Irlab receives positive patent notice in the US for IRL1117 | FW |
Stock exchange
Nasdaq Stockholm- kr
-
0
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| IRLAB A | 2.025SEK | 0.00% | 1.14M kr | ||
Deutsche Boerse AG
| 6IRA | 0.1770EUR | -2.96% | 0 € | |
|
OTC Markets
| IRLAF | -USD | -.--% | 0 $ |
Basic data
Market Cap (SEK)
300,259,041
Market Cap (USD)
30,741,977
Net sales (SEK)
57,462,000
Net sales (USD)
5,883,238
Free-Float
83.4%
Free-Float capitalization (SEK)
143,029,885
Free-Float capitalization (USD)
14,644,093
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 30.74M | |
| +0.61% | +10.62% | +58.16% | +149.73% | 1,255B | |
| +3.81% | +2.82% | +48.35% | +82.58% | 641B | |
| +3.09% | +2.95% | +39.10% | +108.48% | 505B | |
| +1.25% | -0.78% | +52.56% | +66.87% | 381B | |
| +3.93% | +6.02% | +82.28% | +45.44% | 357B | |
| +2.10% | +4.26% | +34.93% | +61.10% | 303B | |
| +1.92% | +9.37% | +13.43% | +36.55% | 286B | |
| +3.73% | +6.82% | +61.48% | +77.31% | 249B | |
| +4.19% | +9.68% | +42.96% | +113.85% | 208B | |
| Average | +1.83% | +2.95% | +48.14% | +82.43% | 418.53B | |
| Weighted average by Cap. | +1.25% | +3.90% | +50.61% | +97.79% |
Historical Quotes: IRLAB Therapeutics AB
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IRLAB A Stock
- Stock
- Quotes IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
